These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8139062)

  • 1. Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?
    Gurewich V; Mittleman M
    JAMA; 1994 Apr; 271(13):1025-6. PubMed ID: 8139062
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly subjects.
    Stober C; Clarke A; Mulvaney A; Harland J; Neithercut WD
    Br J Biomed Sci; 1994 Jun; 51(2):114-8. PubMed ID: 8049607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of high lipoprotein(a) to other traditional atherosclerotic risk factors in patients with coronary heart disease.
    Kim C; Gau GT; Allison TG
    Am J Cardiol; 2003 Jun; 91(11):1360-3. PubMed ID: 12767436
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.
    Rosenson RS
    Arch Intern Med; 1996 Jun; 156(12):1278-84. PubMed ID: 8651835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated lipoprotein(a) and premature coronary heart disease.
    Maher VM; Brown BG
    JAMA; 1997 Jan; 277(3):209; author reply 210. PubMed ID: 9005263
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid abnormalities and coronary heart disease.
    Grundy SM
    Clin Symp; 1997; 49(4):1-32. PubMed ID: 9444788
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease.
    Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T
    Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we measure lipoprotein Lp(a)?
    Wilson PW; Kannel WB
    Arch Intern Med; 1997 Jun; 157(11):1161-2. PubMed ID: 9183225
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a).
    Enas EA; Dhawan J; Petkar S
    Indian Heart J; 1997; 49(1):25-34. PubMed ID: 9130422
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipoprotein(a) and the cardiovascular risk].
    Pedro-Botet J; Sentí M
    Rev Esp Cardiol; 1994 Sep; 47(9):583-6. PubMed ID: 7973023
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH; Rosenson RS
    Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein(a) in coronary heart disease: clinical significance and therapeutic options].
    Leischik R; Dworrak B; Gülker H
    Dtsch Med Wochenschr; 2005 Nov; 130(44):2518-23. PubMed ID: 16252213
    [No Abstract]   [Full Text] [Related]  

  • 14. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management.
    Keller C
    Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) in coronary artery disease in Indian population.
    Govindaraju V; Neelam ; Manjunath CN; Sundar KK
    J Indian Med Assoc; 2003 Aug; 101(8):458-60, 462. PubMed ID: 15071797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a): an important risk factor in coronary artery disease.
    Enas EA; Mehta JL
    J Am Coll Cardiol; 1998 Oct; 32(4):1132-4. PubMed ID: 9768745
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein(a) concentration in various hyperlipidemias.
    Alberty R
    Clin Chim Acta; 1994 Apr; 226(1):105-7. PubMed ID: 8070128
    [No Abstract]   [Full Text] [Related]  

  • 18. Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Jan; 154(2):183-6. PubMed ID: 21996415
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoprotein(A) distribution among adults and its relation to the incidence of coronary artery disease in Changsha City].
    Li X; Zhao S; Wang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):320-2. PubMed ID: 9868086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.